-65.7%
MRNA vs UEC
+198.6%
-264.3%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | UEC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -5.2% | +10.6% | +6.5% |
| 7D | -1.1% | -9.4% | +8.4% | +0.9% |
| 30D | +126.1% | -8.0% | +134.1% | +131.7% |
| 3M | +190.0% | -1.7% | +191.7% | +193.6% |
| 6M | +157.2% | -26.1% | +183.4% | +168.8% |
| YTD | +388.2% | -10.5% | +398.7% | +394.3% |
| 1Y | +467.0% | -13.3% | +480.3% | +470.3% |
| 3Y | +36.1% | +116.4% | -80.3% | +11.1% |
| All | -65.7% | +198.6% | -264.3% | -77.7% |
Cumulative growth
Daily Returns
Daily percentage return beside UEC.
Daily Out/Under-Performance
Portfolio return minus UEC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UEC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded UEC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling